Method of suppressing disease severity of multiple sclerosis using chemokine CXC11
AssigneeRappaport Family Institute for Research in the Medical Sciences
InventorsNathan Karin, Yaniv Zohar, Gizi Wildbaum
Life of this patent
Estimating the term…
Abstract
A method of treating an autoimmune disease such as Multiple Sclerosis is disclosed. The method comprises administering to a subject a therapeutically effective amount of CXCL11. Polypeptides and pharmaceutical compositions for treating same are also disclosed.
Claims5
A method of suppressing disease severity of multiple sclerosis in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of CXCL11 (GeneBank Accession No. AAH05292), thereby suppressing disease severity of multiple sclerosis in the subject.
Dependencies are inferred from the claim text.